These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder. Findling RL, Short EJ, Manos MJ. J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290 [Abstract] [Full Text] [Related]
25. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH. Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069 [Abstract] [Full Text] [Related]
26. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Lawson KA, Johnsrud M, Hodgkins P, Sasané R, Crismon ML. Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786 [Abstract] [Full Text] [Related]
30. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial. Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S. J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402 [Abstract] [Full Text] [Related]
33. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate. Treceño C, Martín Arias LH, Sáinz M, Salado I, García Ortega P, Velasco V, Jimeno N, Escudero A, Velasco A, Carvajal A. Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017 [Abstract] [Full Text] [Related]
34. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD. Zhang H, Du M, Zhuang S. Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150 [Abstract] [Full Text] [Related]
35. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents]. Frölich J, Banaschewski T, Spanagel R, Döpfner M, Lehmkuhl G. Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222 [Abstract] [Full Text] [Related]
36. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder. Huang YS, Chao CC, Wu YY, Chen YY, Chen CK. Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588 [Abstract] [Full Text] [Related]
38. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA. Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289 [Abstract] [Full Text] [Related]
39. [The use of methylphenidate in children: analysis of prescription usage based in routine data of the statutory health insurance bodies concerning drug prescriptions]. Schmidt-Troschke SO, Ostermann T, Melcher D, Schuster R, Erben CM, Matthiessen PF. Gesundheitswesen; 2004 Jun; 66(6):387-92. PubMed ID: 15206042 [Abstract] [Full Text] [Related]
40. Caught in the eye of the storm: a qualitative study of views and experiences of planned drug holidays from methylphenidate in child and adolescent ADHD treatment. Ibrahim K, Vogt C, Donyai P. Child Adolesc Ment Health; 2016 Nov; 21(4):192-200. PubMed ID: 32680336 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]